they are a cancer drug developer, and has no product so far, but again it have every thing to do with the EXPECTATION OF THE COMPANY'S FUTURE EARNINGS
VYS Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues
CYM WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore